Homoeopathic treatment of sciatica pain

Individualized homoeopathic medicines in sciatica pain: A double-blind, randomized, placebo-controlled, pilot trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/10/028617

Enrollment

Registered

2020-10-26

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

Intervention1: Individualized homoeopathic medicines in centesimal potencies: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies, as decided appropriate

dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. All patients will be given general

dosage and repetition depending upon the individual requirement of the cases. All patients will be given general advices on posture maintenance, applying hot fomentation to back, use of firm bed, spin

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients experiencing low back pain radiating to lower limb (unilateral or bilateral) since 3 months or more (2018/19 ICD-10-CM diagnosis code M54.31); confirmed by straight leg raising (SLR) test 2. Age range 18-65 years and patients of either sex 3. Literate patients; ability to read and write in Bengali and/or English 4. Patients providing written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients suffering from uncontrolled diabetes mellitus, cardiovascular diseases, thyroid diseases 2. Patients having history of surgery to the lower back 3. Patients suffering from disc prolapse, psoriatic arthritis and gout, cases willing for or requiring immediate surgical intervention or already underwent any major spinal or hip surgery in last 6 months 4. Patients who are undergoing treatment with NSAIDs during 6 weeks prior to enrolment in the study 5. Spinal corticosteroid injection within 6 months 6. Diagnosed cases of unstable psychiatric illness 7. Pregnant, puerperal and lactating women 8. Self-reported immune-compromised state 9. Substance abuse and/or dependence

Design outcomes

Primary

Measure	Time frame
Sciatica bothersomeness index (SBI) and sciatica frequency index (SFI)Timepoint: At baseline, every month, up to 3 months	—

Secondary

Measure	Time frame
Oswestry LBP questionnaireTimepoint: At baseline, every month, up to 3 months;Roland Morris pain and disability questionnaire (RMPDQ)Timepoint: At baseline, every month, up to 3 months;Short form McGill pain questionnaire (SF-MPQ)Timepoint: At baseline, every month, up to 3 months	—

Countries

India

Contacts

Public ContactProf Dr Shubhamoy Ghosh

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital

drtrishita85@gmail.com8334941727

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026